The biological activity and tissue distribution of 2′,3′-dihydrophylloquinone in rats

Biochimica et Biophysica Acta - General Subjects

Volumn 1622, Issue 3, 2003, Pages 145-150

  Sato, Toshiro ^a   Ozaki, Rumi ^a   Kamo, Shuichi ^a   Hara, Yusuke ^a   Konishi, Satoru ^a   Isobe, Yosuke ^a   Saitoh, Sanshiroh ^a   Harada, Hiroshi ^b  

^a J Oil Mills Inc   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

2 ,3 Dihydrophylloquinone; Menaquinone; Phylloquinone; Tissue distribution; Vitamin K

Indexed keywords

2',3' DIHYDROPHYLLOQUINONE; BLOOD CLOTTING FACTOR; MENAQUINONE; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; UNCLASSIFIED DRUG; WARFARIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BRAIN TISSUE; CARBOXYLATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG TRANSFORMATION; FEMUR; HYDROGENATION; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TESTIS; TISSUE DISTRIBUTION; VITAMIN K DEFICIENCY;

EID: 0042090465     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00135-1     Document Type: Article

References (28)

1. Shearer M.J. Vitamin K and vitamin K-dependent proteins. Br. J. Haematol. 75:1990;156-162.
2. Booth S.L., Suttie J.W. Dietary intake and adequacy of vitamin K. J. Nutr. 128:1998;785-788.
3. 1 during the hydrogenation of vegetable oil. J. Agric. Food Chem. 44:1996;980-983.
4. 1: primary food sources and estimated dietary intakes in the American diet. Lipids. 31:1996;715-720.
5. Booth S.L., McKeown N.M., Lichtenstein A.H., Morse M.O., Davidson K.W., Wood R.J., Gundberg C. A hydrogenated form of vitamin K: its relative bioavailability and presence in the food supply. J. Food Compos. Anal. 13:2000;311-317.
6. Booth S.L., Lichtenstein A.H., O'Brien-Morse M., McKeown N.M., Wood R.J., Saltzman E., Gundberg C.M. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am. J. Clin. Nutr. 74:2001;783-790.
7. Thijssen H.H.W., Drittij-Reijnders M.J. Vitamin K distribution in rats: dietary phylloquinone is a source of tissue menaquinone-4. Br. J. Nutr. 72:1994;415-425.
8. Yamamoto R., Komai M., Kojima K., Furukawa Y., Kimura S. Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats. J. Nutr. Sci. Vitaminol. (Tokyo). 42:1997;133-143.
9. Ronden J.E., Thijssen H.H.W., Vermeer C. Tissue distribution of K-vitamins under different nutritional regimens in the rat. Biochim. Biophys. Acta. 1379:1998;16-22.
10. Davidson R.T., Foley A.L., Engelle J.A., Suttie J.W. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J. Nutr. 128:1998;220-223.
11. Sato T., Ohtani Y., Yamada Y., Saitoh S., Harada H. Difference in the metabolism of vitamin K between liver and bone in vitamin K-deficient rats. Br. J. Nutr. 87:2002;307-314.
12. Suttie J.W. Vitamin K-dependent carboxylase. Annu. Rev. Biochem. 54:1985;459-477.
13. Lian J.B., Friedman P.A. The vitamin K-dependent synthesis of gamma-carboxyglutamic acid by bone microsomes. J. Biol. Chem. 253:1978;6623-6626.
14. Price P.A., Kaneda Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb. Res. 46:1987;121-131.
15. Barone L.M., Aronow M.A., Tassinari M.S., Conlon D., Canalis E., Stein G.S., Lian J.B. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix Gla protein in vitro. J. Cell. Physiol. 160:1994;255-264.
16. 2)-7 by Bacillus subtilis. J. Biosci. Bioeng. 91:2001;16-21.
17. Kindberg C.C., Suttie J.W. Effect of various intakes of phylloquinone on signs of vitamin K deficiency and serum and liver phylloquinone concentrations in the rat. J. Nutr. 119:1989;175-180.
18. van Haarlem L.J.M., Knapen M.H.J., Hamulyak K., Vermeer C. Circulating osteocalcin during oral anticoagulant therapy. Thromb. Haemost. 60:1988;79-82.
19. Pietschmann P., Woloszczuk W., Panzer S., Kyrle P., Smolen J. Decreased serum osteocalcin levels in phenprocoumon-treated patients. J. Clin. Endocrinol. Metab. 66:1988;1071-1074.
20. Bach A.U., Anderson S.A., Foley A.L., Williams E.C., Suttie J.W. Assessment of vitamin K status in human subjects administered "minidose" warfarin. Am. J. Clin. Nutr. 64:1996;894-902.
21. Nishimoto S.K., Price P.A. Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. Evidence from an intracellular precursor. J. Biol. Chem. 255:1980;6579-6583.
22. Nishimoto S.K., Price P.A. The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin. J. Biol. Chem. 260:1985;2382-2386.
23. Binkley N.C., Krueger D.C., Engelke J.A., Foley A.L., Suttie J.W. Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults. Am. J. Clin. Nutr. 72:2000;1523-1528.
24. Price P.A., Williamson M.K., Haba T., Dell R.B., Jee W.S.S. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc. Natl. Acad. Sci. U. S. A. 79:1982;7734-7738.
25. Price P.A., Williamson M.K. Effects of warfarin on bone. J. Biol. Chem. 253:1981;12754-12759.
26. Sokoll J.J., Booth S.L., O'Brien M.E., Davidson K.W., Tsaioun K.I., Sadowski J.A. Changes in serum osteocalcin, plasma phylloquinone, urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am. J. Clin. Nutr. 65:1997;779-784.
27. Binkley N.C., Krueger D.C., Kawahara T.N., Engelke J.A., Chappell R.J., Suttie J.W. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am. J. Clin. Nutr. 76:2002;1055-1060.
28. Thijssen H.H.W., Drittij-Reijnders M.J., Fischer M.A.J.G. Phylloquinone and menaquinone-4 distribution in rats: synthesis rather than uptake determines menaquinone-4 organ concentrations. J. Nutr. 126:1996;537-543.